Encapsulate Awarded $3.63M NASA InSPA Phase 1 Grant to Develop Microgravity-Based Metastasis-on-a-Chip Technology Farmington, CT – Encapsulate, Inc., a precision medicine startup developing advanced biochip systems, has been awarded a $3.63 million Phase 1 grant...
Encapsulate Awarded $1.25M NSF SBIR Phase II Grant to Advance Automated Chemotherapy Selection Platform for Pancreatic and Colorectal Cancers Farmington, CT – Encapsulate, Inc., a precision medicine startup developing automated biochip systems for personalized cancer...
Encapsulate Closes $1.8M Oversubscribed Seed Round to Accelerate Personalized Cancer Therapy Farmington, CT – Encapsulate, a developer of personalized oncology solutions, has raised $1.8 million in seed funding, led by Blackwood Healthcare Breakthroughs, Ambit Health...
News & Events Join our Newsletter Follow us on Linkedin 7 NSF awarded Encapsulate its SBIR Phase I News & Events Live Events Subscribe For the Latest news & Updates Read More Pilot Clinical Studies Completed News & Events Live Events Subscribe For the...
News & Events Join our Newsletter Follow us on Linkedin 7 NSF awarded Encapsulate its SBIR Phase I News & Events Live Events Subscribe For the Latest news & Updates Read More Pilot Clinical Studies Completed News & Events Live Events Subscribe For the...
Encapsulate, an early-stage company founded by three graduate students at the University of Connecticut School of Engineering, was named last month as one of only two winners of the 2019 International Space Station U.S. Laboratory and Boeing “Technology in Space”...
